What is Vasoactive intestinal peptide (VIP)?
The short answer
Vasoactive intestinal peptide, or VIP, is made by the body in the gut and in nerves.
What it is
Studied for its action on smooth muscle in the lungs.
What people look into
Brain
- 3 sources
- Status as of
- How we source
- Ellum doesn't sell peptides.
Get updates on Vasoactive intestinal peptide (VIP)
What it is
- Type
- Neuropeptide
- Also known as
- vip peptide, aviptadil
- How it works
- Studied for its action on smooth muscle in the lungs.
Regulatory status
Not FDA-approved How we label status
As of October 4, 2026, Vasoactive intestinal peptide (VIP) is not FDA-approved for any use and is not on FDA's 503A bulks list.
- Federal (FDA)
- Not FDA-approved
- 503A compounding
- Category 1 (interim; enforcement discretion); not on 216.23 as of 2026-10-07 (as of October 7, 2026)
- PCAC history
- 2016-11-03: voted not to include (vote count not confirmed), FDA proposed exclusion 2019-09-05 (84 FR 46688), never finalized
Timeline
Scroll sideways to see all columns.
Timeline table
| Date | What happened | Source |
|---|---|---|
| Federal Register notice of an FDA Pharmacy Compounding Advisory Committee meeting lists vasoactive intestinal peptide among bulk drug substances under consideration for the 503A bulks list. | Federal Register, event of October 5, 2016, on federalregister.gov | |
| FDA proposed rule lists vasoactive intestinal peptide among bulk drug substances it proposes not to include on the 503A bulks list. | Federal Register, event of September 5, 2019, on federalregister.gov | |
| FDA list of bulk drug substances nominated under section 503A, updated May 14, 2026, places vasoactive intestinal peptide in category 1, under evaluation. | FDA, event of May 14, 2026, on fda.gov |
References
Sources as of October 4, 2026